ZYMtronix, Inc.

Ithaca, NY · Founded 2015 · CIK 0001728037 · Biotech · Private

Cell-free biobased manufacturing platform for producing biochemicals and materials without live cells

zymtronix.com →
Grants
—
No SBIR or STTR on record
Sector median: 1
Raised
$3.6M
3 Form D · Dec 2021
58 months since last filing
Contracts
—
No federal contracts on record
Patents
1
0 granted · 1 pending
Sector median: 2

Capital Timeline

Federal above the line · equity below · node area scaled to amount
Capital and federal award history
DateEventSourceAmount
Private capital raisedForm D · SEC$1,353,179
Private capital raisedForm D · SEC$260,000
Private capital raisedForm D · SEC$2,000,000
Form D · SEC

Peer position

Biotech · 4373 companies · ranked on federal contract value
Biotech companies ranked by federal contract value
#CompanyContractsDisclosed equity
2413SURVEY GENOMICS, INC.——
2414ATLAS BIOLOGICS, LLC——
2415TRIPILL BIOTECHNOLOGY, CORP.——
2416ZYMtronix, Inc.—$3.6M
2417ProFound Therapeutics——
2418ECHOGENESIS THERAPEUTICS INC——
2419VASARYA THERAPEUTICS, INC.——

Ranked on federal contract value rather than capital raised. The equity column is the comparison worth making — companies at the same procurement position often sit at very different points in their funding history.

Founders & Team

From Form D filings · 8 related persons
  • Rob CanizaresDirector
  • Roberto CanizaresDirector
  • Stephane CorgieDirector · Executive Officer
  • Michael HarrisonDirector
  • Wayne MerkelsonDirector · Executive Officer
  • Adam MonroeDirector
  • Gary TrozzoExecutive Officer
  • Herbert YuenDirector

Patents

USPTO · 0 granted of 1
  • Automated Bionanocatalyst Productionapplication

Regulatory activity · Biotech

Sector-level, not company-level

Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.